Share

Jiangxi Sanxin Medtec Co.,Ltd. Stocks

CN¥ 10.08Last Updated 30.04.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 759.37M

Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 10.08
Key Takeaways

Risk factor

Fair trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Jiangxi Sanxin Medtec Co., Ltd. engages in the research and development, manufacture, sale, and service of medical devices in China and internationally. It offers blood purification products, such as centralized dialysate supply systems, hemodialysis water preparation systems, hemodialysis machines, nursing kits for dialysis, central venous catheter packs, arteriovenous spikes, accessories tubing for HDF, dialysate filters, hemodialysis powders and concentrates, hollow fiber hemodialyzers, sterile hemodialysis blood circuits, and tubing sets for hemodialysis. The company also provides infusion and transfusion products, including light-resistant infusion sets, TPE precise filter infusion sets, auto stop fluid precise filter infusion sets, transfusion sets, catheter infusion sets, and precise filter light resistant infusion sets; injections consisting of insulin, dispenser, sterile, and auto-disable syringes; and syringes for fixed dose immunization, hypodermic needles, needleless injection systems, and pneumatic syringes. In addition, it offers indwelling catheter products comprising straight, Y-type, and closed intravenous (IV) catheters; and positive pressure IV catheters, central venous catheter packs, extension tubes with three-way valve, and heparin caps. Further, the company offers blood microembolus filters, disposable extracorporeal circulation tubing kits, cold cardioplegic solution perfusion apparatus, blood containers, medical surgical face masks, disinfectants, and alcohol pads. Jiangxi Sanxin Medtec Co., Ltd. was founded in 1997 and is based in Nanchang, China.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, o

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks